Selected article for: "acute patient and administration subcutaneous intravenous"

Author: Korytkowski, Mary; Antinori-Lent, Kellie; Drincic, Andjela; Hirsch, Irl B; McDonnell, Marie E; Rushakoff, Robert; Muniyappa, Ranganath
Title: A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic
  • Cord-id: u2v1w99n
  • Document date: 2020_6_4
  • ID: u2v1w99n
    Snippet: The pandemic of COVID-19 has presented new challenges to hospital personnel providing care for infected patients with diabetes who represent more than 20% of critically ill patients in intensive care units. Appropriate glycemic management contributes to a reduction in adverse clinical outcomes in acute illness but also requires intensive patient interactions for bedside glucose monitoring, intravenous and subcutaneous insulin administration, as well as rapid intervention for hypoglycemia events.
    Document: The pandemic of COVID-19 has presented new challenges to hospital personnel providing care for infected patients with diabetes who represent more than 20% of critically ill patients in intensive care units. Appropriate glycemic management contributes to a reduction in adverse clinical outcomes in acute illness but also requires intensive patient interactions for bedside glucose monitoring, intravenous and subcutaneous insulin administration, as well as rapid intervention for hypoglycemia events. These tasks are required at a time when minimizing patient interactions is recommended as a way of avoiding prolonged exposure to COVID-19 by health care personnel who often practice in settings with limited supplies of personal protective equipment. The purpose of this manuscript is to provide guidance for clinicians for reconciling recommended standards of care for infected hospitalized patients with diabetes while also addressing the daily realities of an overwhelmed health care system in many areas of the country. The use of modified protocols for insulin administration, bedside glucose monitoring, and medications such as glucocorticoids and hydroxychloroquine that may affect glycemic control are discussed. Continuous glucose monitoring systems have been proposed as an option for reducing time spent with patients, but there are important issues that need to be addressed if these are used in hospitalized patients. On site and remote glucose management teams have potential to provide guidance in areas where there are shortages of personnel who have expertise in inpatient glycemic management.

    Search related documents:
    Co phrase search for related documents
    • active patient and admission day: 1
    • active patient and admission time: 1
    • acute illness and admission day: 1, 2, 3, 4, 5, 6, 7, 8
    • acute illness and admission prior: 1, 2, 3, 4, 5, 6
    • acute illness and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acutely ill and admission day: 1, 2
    • acutely ill and admission prior: 1
    • adjust dose and admission day: 1